Cargando…

Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

Autoimmune bullous diseases are a heterogeneous group of rare conditions clinically characterized by the presence of blisters and/or erosions on the skin and the mucous membranes. Practically, they can be divided into two large groups: the pemphigoid group and the pemphigus group, depending on the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Astolto, Roberto, Quintarelli, Lavinia, Corrà, Alberto, Caproni, Marzia, Fania, Luca, Di Zenzo, Giovanni, Didona, Biagio, Gasparini, Giulia, Cozzani, Emanuele, Feliciani, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518530/ https://www.ncbi.nlm.nih.gov/pubmed/37753233 http://dx.doi.org/10.4081/dr.2023.9641

Ejemplares similares

Linear IGA bullous dermatosis potentially triggered by vaccination
por: Corrà, Alberto, et al.
Publicado: (2022)

Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study
por: Maronese, Carlo Alberto, et al.
Publicado: (2022)

Cicatricial alopecia associated with pemphigus
por: D'Astolto, Roberto, et al.
Publicado: (2023)

Humoral Epitope Spreading in Autoimmune Bullous Diseases
por: Didona, Dario, et al.
Publicado: (2018)

Response: Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study
por: Pira, Anna, et al.
Publicado: (2023)

Absolving COVID-19 Vaccination of Autoimmune Bullous Disease Onset
por: Russo, Roberto, et al.
Publicado: (2022)

Exacerbation of generalized plaque psoriasis after tuberculin test
por: Corrà, Alberto, et al.
Publicado: (2021)

Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?
por: Russo, Roberto, et al.
Publicado: (2020)

Autoantibody Profile of a Cohort of 54 Italian Patients with Linear IgA Bullous Dermatosis: LAD-1 Denoted as a Major Auto-antigen of the Lamina Lucida Subtype
por: COZZANI, Emanuele, et al.
Publicado: (2020)

Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience
por: Merli, Martina, et al.
Publicado: (2023)

Granulomatous Dermatitis and Systemic Disease: An Association to Consider
por: Corrà, Alberto, et al.
Publicado: (2020)

Paraneoplastic Dermatoses: A Brief General Review and an Extensive Analysis of Paraneoplastic Pemphigus and Paraneoplastic Dermatomyositis
por: Didona, Dario, et al.
Publicado: (2020)

May bullous pemphigoid be worsened by COVID-19 vaccine?
por: Cozzani, Emanuele, et al.
Publicado: (2022)

New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update
por: Genovese, Giovanni, et al.
Publicado: (2019)

Case report: Bullous pemphigoid arising in a patient with scleroderma and multiple sclerosis
por: Moro, Francesco, et al.
Publicado: (2022)

Bullous Pemphigoid: Trigger and Predisposing Factors
por: Moro, Francesco, et al.
Publicado: (2020)

The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targets
por: Maglie, Roberto, et al.
Publicado: (2023)

Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening
por: Di Zenzo, Giovanni, et al.
Publicado: (2022)

Neutrophil Gelatinase-Associated Lipocalin as Potential Predictive Biomarker of Melanoma and Non-Melanoma Skin Cancers in Psoriatic Patients: A Pilot Study
por: Verdelli, Alice, et al.
Publicado: (2022)

Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients
por: Gasparini, Giulia, et al.
Publicado: (2023)

Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic
por: Corrà, Alberto, et al.
Publicado: (2021)

156 COVID-19 vaccine is a risk factor accelerating time to bullous pemphigoid onset
por: Pira, A., et al.
Publicado: (2023)

Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis
por: Aimo, Cristina, et al.
Publicado: (2022)

An update on the management of refractory cutaneous lupus erythematosus
por: Verdelli, Alice, et al.
Publicado: (2022)

Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination
por: Corrà, Alberto, et al.
Publicado: (2022)

Rituximab in Mucous Membrane Pemphigoid: A Monocentric Retrospective Study in 10 Patients with Severe/Refractory Disease
por: Baffa, Maria Efenesia, et al.
Publicado: (2022)

Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine
por: Pira, Anna, et al.
Publicado: (2023)

Five cases of new‐onset pemphigus following vaccinations against coronavirus disease 2019
por: Corrá, Alberto, et al.
Publicado: (2022)

The impact on the scientific community of the 2018 addendum to the CHCC
por: Caproni, Marzia, et al.
Publicado: (2022)

Editorial: Autoimmune blistering diseases: advances in the understanding of pathogenesis and new therapeutic horizons
por: Gasparini, Giulia, et al.
Publicado: (2023)

Skin gluten-related disorders: new and old cutaneous manifestations to be considered
por: Verdelli, Alice, et al.
Publicado: (2023)

Reply letter to “An update on direct immunofluorescence for diagnosing dermatitis herpetiformis”. Could granular C3 deposits at the dermal epidermal junction be considered a marker of “cutaneous gluten sensitivity”?
por: Alice, Verdelli, et al.
Publicado: (2021)

Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022)

Case Report: Resolution of Lichen Planus Pemphigoides as an unexpected outcome of SARS-CoV-2 infection
por: Ruffo di Calabria, Valentina, et al.
Publicado: (2023)

Generalized acquired cutis laxa and urticarial dermatosis associated with k-chain IgA micromolecular myeloma
por: Moretta, Gaia, et al.
Publicado: (2021)

Dermatitis Herpetiformis: Novel Perspectives
por: Antiga, Emiliano, et al.
Publicado: (2019)

Multicentric Reticulohistiocytosis Associated with an Early Form of Systemic Lupus Erythematosus: A Case Report of a Rare Disease, with Mini Review of the Literature
por: Mariotti, Elena Biancamaria, et al.
Publicado: (2022)

Self‐resolving bullous pemphigoid induced by cemiplimab
por: Molle, Mattia Fabio, et al.
Publicado: (2022)

The Autoimmune Bullous Diseases
por: Wakelin, S H, et al.
Publicado: (1997)

Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
por: Cozzani, Emanuele, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0aj3pnnanq1jk73ihi148hgjgk